We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
-$1.13B
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,446
Increased
2,646
Reduced
3,048
Closed
1,267

Sector Composition

Rank Sector Weight
1 Technology 7.41%
2 Consumer Discretionary 6.04%
3 Financials 5.89%
4 Industrials 4.61%
5 Healthcare 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAMR icon
5651
CALL
Lamar Advertising Co
LAMR
$15.8B
$314K ﹤0.01%
4,200
-2,500
-37% -$188K
MOV icon
5652
PUT
Movado Group
MOV
$803M
$314K ﹤0.01%
+12,600
New +$319K
KCG
5653
PUT
DELISTED
KCG Holdings, Inc.
KCG
$314K ﹤0.01%
17,600
-24,200
-58% -$360K
BOKF icon
5654
PUT
BOK Financial
BOKF
$8.88B
$313K ﹤0.01%
+4,000
New +$326K
CLLS
5655
Cellectis
CLLS
$296M
$313K ﹤0.01%
13,026
CTMX icon
5656
CytomX Therapeutics
CTMX
$732M
$313K ﹤0.01%
+18,116
New +$238K
ERIC icon
5657
PUT
Ericsson
ERIC
$33.6B
$313K ﹤0.01%
47,200
-10,400
-18% -$64.2K
KYNB
5658
CALL
Kyntra Bio
KYNB
$28.5M
$313K ﹤0.01%
508
-240
-32% -$146K
PTF icon
5659
Invesco Dorsey Wright Technology Momentum ETF
PTF
$676M
$313K ﹤0.01%
20,979
-73,770
-78% -$1.05M
HGI
5660
DELISTED
Invesco Zacks International Multi-Asset Income ETF
HGI
$313K ﹤0.01%
19,586
-19,941
-50% -$314K
AGQ icon
5661
ProShares Ultra Silver
AGQ
$1.43B
$312K ﹤0.01%
+7,567
New +$290K
CRVL icon
5662
CorVel
CRVL
$3.32B
$312K ﹤0.01%
21,528
-28,095
-57% -$370K
RARE icon
5663
CALL
Ultragenyx Pharmaceutical
RARE
$2.61B
$312K ﹤0.01%
4,600
-3,200
-41% -$244K
TRMB icon
5664
Trimble
TRMB
$13.4B
$312K ﹤0.01%
+9,742
New +$301K
AVID
5665
DELISTED
Avid Technology Inc
AVID
$312K ﹤0.01%
66,776
+44,808
+204% +$232K
COUP
5666
PUT
DELISTED
Coupa Software Incorporated
COUP
$312K ﹤0.01%
+12,300
New +$314K
FRAN
5667
CALL
DELISTED
Francesca's Holdings Corporation
FRAN
$312K ﹤0.01%
+1,692
New +$350K
WPG
5668
PUT
DELISTED
Washington Prime Group Inc.
WPG
$312K ﹤0.01%
3,989
+911
+30% +$76.3K
EFU icon
5669
CALL
ProShares Trust UltraShort MSCI EAFE
EFU
$1.13M
$311K ﹤0.01%
5,050
+1,500
+42% +$98.6K
FSM icon
5670
PUT
Fortuna Silver Mines
FSM
$3.16B
$311K ﹤0.01%
59,900
+5,700
+11% +$33.7K
PEGA icon
5671
CALL
Pegasystems
PEGA
$5.31B
$311K ﹤0.01%
+14,200
New +$288K
TGTX icon
5672
PUT
TG Therapeutics
TGTX
$7.46B
$311K ﹤0.01%
26,700
+15,600
+141% +$112K
AMAG
5673
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
$311K ﹤0.01%
13,800
+2,400
+21% +$57.5K
POOL icon
5674
PUT
Pool Corp
POOL
$7.08B
$310K ﹤0.01%
2,600
+500
+24% +$56K
RSO
5675
PUT
DELISTED
Resource Capital Corp.
RSO
$310K ﹤0.01%
31,700
+12,900
+69% +$112K

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors's Q1 2017 filing shows 1,446 new, 2,646 increased, 3,048 reduced and 1,267 closed positions. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M. The largest sale was Alphabet (Google) Class A, an estimated $482M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 5.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,446 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.